Investors 1
| Date | Name | Website |
| - | LAV | lavfund.co... |
Mentions in press and media 2
| Date | Title | Description |
| 10.01.2022 | Virtue Diagnostics Raises $100M in Series B Funding | Virtue Diagnostics, a Singapore and Shanghai, China-based IVD company focused on infectious disease, cancer, and chronic diseases, raised $100M in Series B funding. The round was led by Sequoia China and Morningside Ventures with participat... |
| 06.01.2022 | Virtue Diagnostics closes $100 million Series B Funding | SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging ma... |